Document is current
Any future updates will be listed below
-
Authors
Gelineau-Morel, Rose
Usman, Fatima
Shehu, Saadatu
Yeh, Hung-Wen
Suwaid, Mohammad A.
Abdulsalam, Mohammed
Jibril, Yasir
Satrom, Katherine M.
Shapiro, Steven M.
Zinkus, Timothy P.
Head, Hayden W.
Slusher, Tina M.
Le Pichon, Jean-Baptiste
Farouk, Zubaida L.
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD069038)
- License Information
-
More Information
Article History
Received: 24 February 2023
Revised: 26 July 2023
Accepted: 14 August 2023
First Online: 9 September 2023
Competing interests
: R.G.-M. is supported by the NICHD (grant number T32HD069038). She has received a travel grant from the American Society of Clinical Pharmacology and Therapeutics and has a provisional patent for a novel drug for the treatment of movement disorders. F.U. and S.S. declared internal funding from Children’s Mercy Hospital to support patient MRI costs for the study. T.S. declared internal funding for travel and hotel only from Children’s Mercy Hospital related to this study. J.-B.L.P. declared internal funding from Children’s Mercy Hospital to support the costs of this study. He also serves on the editorial board of Pediatric Neurology and Annals of Child Neurology Society and is a clinical advisory round table member for the Firefly Fund for Neimann Pick type C. J.-B.L.P. also provides medical expertize on an occasional basis to various law firms. All other authors declare no conflicts of interest.
: Participant families provided informed consent for this study through the Aminu Kano Teaching Hospital, Nigeria.
